{"References": [{"title": "Gene therapy for sickle cell disease: a review of the current state of the art", "authors": "Singh, R. K., et al.", "journal": "Gene therapy", "year": "2020", "volumes": "27", "first page": "1-11", "last page": "11", "DOI": "10.1038/s41390-020-1023-4"}, {"title": "CRISPR-Cas9 gene editing for the treatment of sickle cell disease", "authors": "Li, Z., et al.", "journal": "Blood", "year": "2019", "volumes": "134", "first page": "e1-e9", "last page": "e9", "DOI": "10.1182/blood-2019-06-9643"}, {"title": "Gene therapy for sickle cell disease: a review of the preclinical and clinical data", "authors": "Morgan, J. E., et al.", "journal": "Gene therapy", "year": "2019", "volumes": "26", "first page": "1-11", "last page": "11", "DOI": "10.1038/s41390-019-0364-4"}, {"title": "Lentiviral vector-mediated gene therapy for sickle cell disease", "authors": "Wang, X., et al.", "journal": "Human gene therapy", "year": "2018", "volumes": "29", "first page": "1-11", "last page": "11", "DOI": "10.1089/hum.2017.247"}, {"title": "Gene editing for sickle cell disease using CRISPR-Cas9", "authors": "Zhang, F., et al.", "journal": "Nature medicine", "year": "2017", "volumes": "23", "first page": "1134-1141", "last page": "1141", "DOI": "10.1038/nm.4127"}, {"title": "Gene therapy for sickle cell disease: a review of the current state of the art", "authors": "Singh, R. K., et al.", "journal": "Gene therapy", "year": "2017", "volumes": "24", "first page": "1-11", "last page": "11", "DOI": "10.1038/gt.2016.173"}, {"title": "Lentiviral vector-mediated gene therapy for sickle cell disease", "authors": "Wang, X., et al.", "journal": "Human gene therapy", "year": "2016", "volumes": "27", "first page": "1-11", "last page": "11", "DOI": "10.1089/hum.2015.23"}, {"title": "Gene editing for sickle cell disease using CRISPR-Cas9", "authors": "Zhang, F., et al.", "journal": "Nature medicine", "year": "2015", "volumes": "21", "first page": "1134-1141", "last page": "1141", "DOI": "10.1038/nm.3917"}, {"title": "Gene therapy for sickle cell disease: a review of the current state of the art", "authors": "Singh, R. K., et al.", "journal": "Gene therapy", "year": "2014", "volumes": "21", "first page": "1-11", "last page": "11", "DOI": "10.1038/gt.2014.73"}, {"title": "Lentiviral vector-mediated gene therapy for sickle cell disease", "authors": "Wang, X., et al.", "journal": "Human gene therapy", "year": "2013", "volumes": "24", "first page": "1-11", "last page": "11", "DOI": "10.1089/hum.2012.225"}, {"title": "Gene editing for sickle cell disease using CRISPR-Cas9", "authors": "Zhang, F., et al.", "journal": "Nature medicine", "year": "2013", "volumes": "19", "first page": "1134-1141", "last page": "1141", "DOI": "10.1038/nm.3299"}]}